A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles

Journal of Controlled Release

Volumn 93, Issue 2, 2003, Pages 183-191

  Jeong, Ji Hoon ^a   Kim, Sung Wan ^a,b   Park, Tae Gwan ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Conjugate; Delivery; Micelles; ODN; PEG

Indexed keywords

CELLS; HYDRODYNAMICS; POLYELECTROLYTES; POLYETHYLENE GLYCOLS; SOLUTIONS; TUMORS;

ANTIPROLIFERATIVE ACTIVITIES;

MICELLES;

ANTISENSE OLIGONUCLEOTIDE; MACROGOL; POLYELECTROLYTE; POLYETHYLENEIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; CANCER GROWTH; CARCINOMA CELL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDRODYNAMICS; MICELLE; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0242494161     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2003.07.002     Document Type: Conference Paper

References (38)

1. Stein C.A., Cheng Y.C. Anti-sense oligonucleotides as therapeutic agents - is the bullet really magical? Science. 261:1993;1004-1012.
2. Crooke S.T. Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEB J. 7:1993;533-539.
3. Gewirtz A.M., Sokol D.L., Ratajczak M.Z. Nucleic acid therapeutics: state of the art and future prospects. Blood. 92:1998;712-736.
4. Bennett C.F. Anti-sense oligonucleotides: is the glass half full or half empty? Biochem. Pharmacol. 55:1998;9-19.
5. Calabretta B., Skorski T., Ratajczak M.Z., Gewirtz A.M. Anti-sense strategies in the treatment of leukemias. Semin. Oncol. 23:1996;78-87.
6. Skorski T., Nieborowska-Skorska M., Wlodarski P., Zon G., Iozzo R.V., Calabretta B. Anti-sense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice. Blood. 88:1996;1005-1012.
7. Bennett M.R., Anglin S., McEwan J.R., Jagoe R., Newby A.C., Evan G.I. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc anti-sense oligodeoxynucleotides. J. Clin. Invest. 93:1994;820-828.
8. Simons M., Edelman E.R., DeKeyser J.L., Langer R., Rogenberg R.D. Anti-sense c-myc oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature. 359:1992;67-70.
9. Wagner R.W. Gene inhibition using anti-sense oligodeoxynucleotides. Nature. 372:1994;333-335.
10. Li S., Deshmukh H.M., Huang L. Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells. Pharm. Res. 15:1998;1540-1545.
11. Agrawal S., Goodchild J., Civeira M.P., Thornton A.H., Sarin P.S., Zamecnik P.C. Oligodeoxy-nucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 85:1988;7079-7083.
12. Egholm M., Buchardt O., Christensen L., Behrens C., Frier S.M., Driver D.A., Berg R.H., Kim S.K., Norde'n B., Nielsen P.E. PNA hybridizes to complementary oligo-nucleotides obeying the Watson-Crick hydrogen bonding rules. Nature. 365:1993;566-568.
13. Pagnan G., Stuart D.D., Pastorino F., Raffaghello L., Montaldo P.G., Allen T.M., Calabretta B., Ponzoni M. Delivery of c-myb anti-sense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD 2-targeted immunoliposomes: antitumor effects. J. Natl. Cancer Inst. 92:2000;253-261.
14. Juliano R.L., Akhtar S. Liposomes as a drug delivery system for anti-sense oligonucleotides. Antisense Res. Dev. 2:1992;165-176.
15. Meyer O., Kirpotin D., Hong K., Sternberg B., Park J.W., Woodlei M.C., Papahadjopoulos D. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. J. Biol. Chem. 25:1998;15621-15627.
16. Kim J.S., Kim B.-I., Maruyama A., Akaike T., Kim S.W. A new non-viral DNA delivery vector: the terplex system. J. Control. Release. 53:1998;175-182.
17. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scheman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 92:1995;7297-7303.
18. Chavany C., Doan T.L., Couvreur P., Puisieux F., Helene C. Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides. Pharm. Res. 9:1992;441-449.
19. Kataoka K., Togawa H., Harada A., Yasugi K., Matsumoto T., Katoyose S. Spontaneous formation of polyion complex micelles with narrow distribution from anti-sense oligonucleotide and cationic block copolymer in physiological saline. Macromolecules. 29:1996;8556-8557.
20. Katayose S., Kataoka K. Water-soluble polyion complex associates of DNA and poly(ethyeneglycol)-poly(L-lysine) block copolymer. Bioconjug. Chem. 8:1997;702-707.
21. Katayose S., Kataoka K. Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethyleneglycol)-poly(L- lysine) block copolymer. J. Pharm. Sci. 87:1998;160-163.
22. Harada A., Togawa H., Kataoka K. Physicochemical properties and nuclease resistance of anti-sense-oligonucleotides entrapped in the core of polyion complex micelles composed of poly(ethyeneglycol)-poly(L-lysine) block copolymer. Eur. J. Pharm. Sci. 13:2001;35-42.
23. Kakizawa Y., Harada A., Kataoka K. Glutathione-sensitive stabilization of block copolymer micelles composed of antisense DNA and thiolated poly(ethylene glycol)-block-poly(L-lysine): a potential carrier for systemic delivery of antisense DNA. Biomacromolecules. 2:2001;491-497.
24. Vinogradov S.V., Bronich T.K., Kabanov A.V. Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. Bioconjug. Chem. 9:1998;805-812.
25. Vinogradof S., Batrakova E., Li S., Kabanov A. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. Bioconjug. Chem. 10:1999;851-860.
26. Choi Y.H., Liu F., Choi J.S., Kim S.W., Park J.S. Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine, and its complex with plasmid DNA. Hum. Gene Ther. 10:1999;2657-2665.
27. Lee H., Jeong J.H., Park T.G. A new gene delivery formulation of polyethyleneimine/DNA complexes coated with PEG conjugated fusogenic peptide. J. Control. Release. 76:2001;138-192.
28. Lee H., Jeong J.H., Park T.G. PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. J. Control. Release. 79:2002;283-291.
29. Jeong J.H., Park T.G. Novel polymer-DNA hybrid polymeric micelles composed of hydrophobic poly(D,L-lactic-co-glycolic acid) and hydrophilic oligonucleotides. Bioconjug. Chem. 12:2001;917-923.
30. Jeong J.H., Kim S.W., Park T.G. Novel intra-cellular delivery system of anti-sense oligonucleotide by self-assembled hybrid micelles composed of DNA/ PEG conjugate and cationic fusogenic peptide. Bioconjug. Chem. 14:2003;473-479.
31. Monia B.P., Johnston J.F., Geiger T., Muller M., Fabbro D. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against c-Raf kinase. Nat. Med. 2:1996;668-675.
32. McPhillips F., Mullen P., Monia B.P., Ritchie A.A., Dorr F.A., Smyth J.F., Langdon S.P. Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer. Br. J. Cancer. 85:2001;1753-1758.
33. Stevenson J.P., Yao K.S., Gallagher M., Friedland D., Mitchell E.P., Cassella A., Monia B., Kwoh T.J., Yu R., Holmlund J., Dorr F.A., O'Dwyer P.J. Phase I clinical/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A). J. Clin. Oncol. 17:1999;2227-2236.
34. Cunningham C.C., Holmlund J.T., Schiller J.H., Geary R.S., Kwoh T.J., Dorr A., Nemunaitis J. A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer. Clin. Cancer Res. 6:2000;1626-1631.
35. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods. 65:1983;55-63.
36. Liaw J., Aoyagi T., Kataoka K., Sakurai Y., Okano T. Permeation of PEO-PBLA-FITC polymeric micelles in aortic endothelial cells. Pharm. Res. 16:1999;213-220.
37. Daum G., Eisenmann-Tapp I., Fries H.-W., Troppmair J., Rapp U.R. The ins and outs of raf kinases. TIBS. 19:1994;474-480.
38. Maeda H., Wu J., Saga T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release. 65:2000;271-284.